Elena Nikiphorou provides her thoughts on the findings of this trial showing a normalization of mortality in patients with rheumatoid arthritis receiving early, intensive treatment (2:41).
14-06-2018 | Rheumatoid arthritis | EULAR 2018 | Video
Browse topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA
Anifrolumab for the treatment of SLE
JAK inhibitor safety: Weighing up the data and understanding the risks
Rituximab and rheumatology practice in the COVID-19 era
Safety snapshot: Upadacitinib in patients with PsA
Repurposing rheumatology drugs for COVID-19
Telemedicine in rheumatology: COVID-19 and beyond
Managing PsA in resource-limited settings
Conferences